Friday, December 27, 2019

Gland Pharma Limited Walk in Interviews for AR&D / FR&D on 30th December 2019

Gland Pharma Limited Walk in Interviews for AR&D

 / FR&D on 30th December 2019 

Walk in Interviews for AR&D / FR&D @ Gland Pharma Ltd

Dear Applicant,

Greetings from Gland Pharma Limited!!

We have urgent Requirement for AR&D department. if you are interested you can walk-in 
for an interaction on 30th December 2019 Between 09.00 AM to 10.30 AM.

Please have a glimpse on below Job Description;

* Exposure on Method Development and Method validations.

* Hands on experience on HPLC, UV, IR, GC, and Potentiometer.

* Maintain Good Laboratory Practices.

* Maintain Good Documentation Practices.

Job Specification:

Experience: 1 to 4 Years

We have urgent Requirement for FR&D department. if you are interested you can walk-in for an interaction on 30th December 2019 Between 09.00 AM to 10.30 AM.

Please have a glimpse on below Job Description;

·         Literature survey, pre-formulation studies and formulation trials leading to identifying a suitable composition for the product.

·         Attending the exhibit/pilot batches manufacture

·         Preparation of technical regulatory documentation to support

·         Development work (includes protocols, reports, laboratory note books and batch records) on Injectable.

Job Specification:

Experience: 1 to 4 Years

Injectable experience is Mandatory.

Documents Required:

·         Passport size Photograph 4 Nos.

·         Your updated resume

·         Photocopies of Qualification certificates

·         Photocopies of Aadhar Card/Pancard

·         Experience/Service certificates

·         Salary certificate / latest three months pay slip from the present employer with supporting bank statement/ CTC Structure.

Venue Details;

Gland Pharma Ltd.

Near Gandimaisamma cross roads,

D.P.Pally, Dundigal (post),

Hyderabad-43

Land Mark: Next to Dundigal Police Station

Contact Person. Praveen Kumar Madapati - HR



FOR MORE JOB UPDATES



JOIN IN GROUP FOR DAILY UPDATES


No comments:

Post a Comment